220 related articles for article (PubMed ID: 11896584)
21. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.
Schwab TS; Madison BB; Grauman AR; Feldman EL
Apoptosis; 2005 Aug; 10(4):831-40. PubMed ID: 16133873
[TBL] [Abstract][Full Text] [Related]
23. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
[TBL] [Abstract][Full Text] [Related]
24. FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1.
Bakker WJ; Blázquez-Domingo M; Kolbus A; Besooyen J; Steinlein P; Beug H; Coffer PJ; Löwenberg B; von Lindern M; van Dijk TB
J Cell Biol; 2004 Jan; 164(2):175-84. PubMed ID: 14734530
[TBL] [Abstract][Full Text] [Related]
25. STAT1 is involved in signal transduction in the EPO induced HEL cells.
Chu J; Gui CY; Fan J; Tang XD; Qiao RL
Cell Res; 1998 Jun; 8(2):105-17. PubMed ID: 9669026
[TBL] [Abstract][Full Text] [Related]
26. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation.
Furuyama T; Kitayama K; Yamashita H; Mori N
Biochem J; 2003 Oct; 375(Pt 2):365-71. PubMed ID: 12820900
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phosphorylation of a forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin.
Arimoto-Ishida E; Ohmichi M; Mabuchi S; Takahashi T; Ohshima C; Hayakawa J; Kimura A; Takahashi K; Nishio Y; Sakata M; Kurachi H; Tasaka K; Murata Y
Endocrinology; 2004 Apr; 145(4):2014-22. PubMed ID: 14701673
[TBL] [Abstract][Full Text] [Related]
28. Regulation of FOXO3a by brain-derived neurotrophic factor in differentiated human SH-SY5Y neuroblastoma cells.
Zhu W; Bijur GN; Styles NA; Li X
Brain Res Mol Brain Res; 2004 Jul; 126(1):45-56. PubMed ID: 15207915
[TBL] [Abstract][Full Text] [Related]
29. Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells.
Muta K; Krantz SB; Bondurant MC; Wickrema A
J Clin Invest; 1994 Jul; 94(1):34-43. PubMed ID: 7518834
[TBL] [Abstract][Full Text] [Related]
30. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
31. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
32. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.
Youn HD; Chatila TA; Liu JO
EMBO J; 2000 Aug; 19(16):4323-31. PubMed ID: 10944115
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells.
Penta K; Sawyer ST
J Biol Chem; 1995 Dec; 270(52):31282-7. PubMed ID: 8537396
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
Josefsen D; Myklebust JH; Lømo J; Sioud M; Blomhoff HK; Smeland EB
Stem Cells; 2000; 18(4):261-72. PubMed ID: 10924092
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
36. The coactivator p300 directly acetylates the forkhead transcription factor Foxo1 and stimulates Foxo1-induced transcription.
Perrot V; Rechler MM
Mol Endocrinol; 2005 Sep; 19(9):2283-98. PubMed ID: 15890677
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.
Anderson MJ; Viars CS; Czekay S; Cavenee WK; Arden KC
Genomics; 1998 Jan; 47(2):187-99. PubMed ID: 9479491
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt.
del Peso L; González VM; Hernández R; Barr FG; Núñez G
Oncogene; 1999 Dec; 18(51):7328-33. PubMed ID: 10602488
[TBL] [Abstract][Full Text] [Related]
39. FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins.
Scheijen B; Ngo HT; Kang H; Griffin JD
Oncogene; 2004 Apr; 23(19):3338-49. PubMed ID: 14981546
[TBL] [Abstract][Full Text] [Related]
40. DAF-16 recruits the CREB-binding protein coactivator complex to the insulin-like growth factor binding protein 1 promoter in HepG2 cells.
Nasrin N; Ogg S; Cahill CM; Biggs W; Nui S; Dore J; Calvo D; Shi Y; Ruvkun G; Alexander-Bridges MC
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10412-7. PubMed ID: 10973497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
